Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Alessandro, Andriani"'
Autor:
Federica Petrone, Carmine Gizzi, Alessandro Andriani, Vincenza Martini, Roberta Sala, Angela Abballe, Lucia Capoccetta, Angela Spicciato, Marco Alfio Cutuli, Antonio Guarnieri, Noemi Venditti, Roberto Di Marco, Giulio Petronio Petronio
Publikováno v:
Microorganisms, Vol 12, Iss 7, p 1296 (2024)
Background: The COVID-19 pandemic has made antibiotic resistance (AMR) and healthcare-acquired infections (HAIs) increasingly serious problems. Point-prevalence Surveys (PPS) and other surveillance techniques are essential for antimicrobial managemen
Externí odkaz:
https://doaj.org/article/2dd24147a91146ad8fb50d5087426c7b
Autor:
alessandro andriani, Laura Marchetti, Fabio Rossi, Silvia Raja, Maria Antonietta Perretti, Umberto Recine
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/30f0b6590189471ca8ca2f794118c803
Autor:
Francesca Palandri, Elena M. Elli, Giuseppe Auteri, Massimiliano Bonifacio, Giulia Benevolo, Florian H. Heidel, Simona Paglia, Malgorzata M. Trawinska, Costanza Bosi, Elena Rossi, Mario Tiribelli, Alessia Tieghi, Alessandra Iurlo, Nicola Polverelli, Giovanni Caocci, Gianni Binotto, Francesco Cavazzini, Eloise Beggiato, Daniela Cilloni, Caterina Tatarelli, Francesco Mendicino, Maurizio Miglino, Monica Bocchia, Monica Crugnola, Camilla Mazzoni, Andrea D. Romagnoli, Giovanni Rindone, Sara Ceglie, Alessandra D’Addio, Eleonora Santoni, Daniele Cattaneo, Daniela Bartoletti, Roberto M. Lemoli, Mauro Krampera, Antonio Cuneo, Gianpietro C. Semenzato, Roberto Latagliata, Elisabetta Abruzzese, Nicola Vianelli, Michele Cavo, Alessandro Andriani, Valerio De Stefano, Giuseppe A. Palumbo, Massimo Breccia
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-5 (2023)
Externí odkaz:
https://doaj.org/article/142637191ad84c61a603c3e424c76be2
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 266-268 (2023)
Abstract Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in western countries. The association between CLL and glomerular disease (GD) is rare. The most frequent GD associated with CLL is membranoproliferative membranous glomer
Externí odkaz:
https://doaj.org/article/b0bb8dfbd4f74850b1e4c2367bfcfdd9
Autor:
Francesca Fazio, Luca Franceschini, Valeria Tomarchio, Angela Rago, Maria Grazia Garzia, Luca Cupelli, Velia Bongarzoni, Alessandro Andriani, Svitlana Gumenyuk, Agostino Tafuri, Agostina Siniscalchi, Alfonso Piciocchi, Paolo De Fabritiis, Luca De Rosa, Tommaso Caravita di Toritto, Ombretta Annibali, Maria Cantonetti, Maria Teresa Petrucci
Publikováno v:
eJHaem, Vol 3, Iss 1, Pp 121-128 (2022)
Abstract The multiple myeloma (MM) treatment has changed over the last years due to the introduction of novel drugs. Despite improvements in the MM outcome, MM remains an incurable disease. Daratumumab is a human IgGK monoclonal antibody targeting CD
Externí odkaz:
https://doaj.org/article/08a8f52370794db1965593a53d936007
Autor:
Francesco Autore, Idanna Innocenti, Francesco Corrente, Maria Ilaria Del Principe, Serena Rosati, Paolo Falcucci, Alberto Fresa, Esmeralda Conte, Maria Assunta Limongiello, Daniela Renzi, Laura De Padua, Alessandro Andriani, Francesco Pisani, Giuseppe Cimino, Agostino Tafuri, Marco Montanaro, Francesca Romana Mauro, Giovanni Del Poeta, Luca Laurenti
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Previous studies investigated the efficacy and the safety of bendamustine (B) vs. chlorambucil (Chl) associated with rituximab (R) in fludarabine-ineligible patients with treated and untreated chronic lymphocytic leukemia (CLL). We conducted a retros
Externí odkaz:
https://doaj.org/article/866f76aca36148178f8b771ba97e31c6
Publikováno v:
eJHaem. 4:266-268
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::335697194632d73f75df01bc9b4371e7
https://doi.org/10.1002/jha2.592
https://doi.org/10.1002/jha2.592
Autor:
Sara Pepe, Elena Rossi, Malgorzata Trawinska, Caterina Tatarelli, Ambra Di Veroli, Luca Maurillo, Atelda Romano, Sabrina Leonetti Crescenzi, Tommaso Caravita di Toritto, Agostino Tafuri, Roberto Latagliata, Emilia Scalzulli, Alessandro Andriani, Valerio De Stefano, Massimo Breccia
Publikováno v:
Annals of Hematology. 101:1275-1282
Ruxolitinib is approved for polycythemia vera (PV) patients after failure to previous cytoreductive therapy, based on durable results observed in phase 3 trials. We report a multicenter retrospective study demonstrating the efficacy and safety of rux
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d1684178c8a95bbddc18767dce3e1b7
https://doi.org/10.1007/s00277-022-04815-w
https://doi.org/10.1007/s00277-022-04815-w
Autor:
Flavia Mayer, Laura Faglioni, Nera Agabiti, Susanna Fenu, Francesco Buccisano, Roberto Latagliata, Roberto Ricci, Maria Antonietta Aloe Spiriti, Caterina Tatarelli, Massimo Breccia, Giuseppe Cimino, Luana Fianchi, Svitlana Gumenyuk, Stefano Mancini, Luca Maurillo, Carolina Nobile, Pasquale Niscola, Anna Lina Piccioni, Agostino Tafuri, Giulio Trapè, Alessandro Andriani, Paolo De Fabritis, Maria Teresa Voso, Marina Davoli, Gina Zini
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 9, Iss 1, Pp e2017046-e2017046 (2017)
Results on myelodysplastic syndromes (MDS) from population-based studies are rare and these data are infrequently collected by cancer registries because diagnostic difficulties and under-reported data. Our is the first regional Lazio study about med
Externí odkaz:
https://doaj.org/article/fc219b75f34c456f8ab38e42e8dd569b
Autor:
Alessandro Andriani, Massimo Breccia, Emilia Scalzulli, Elisabetta Cerchiara, Atelda Romano, Annalisa Biagi, Luca Maurillo, Malgorzata Monika Trawinska, Katia Paciaroni, Michelina Santopietro, Sabrina Leonetti Crescenzi, Ada D'Addosio, Caterina Tatarelli, Elisabetta Abruzzese, Ambra Di Veroli, Elena Rossi, Roberto Latagliata, Marco Montanaro
Publikováno v:
Blood. 140:12211-12212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1a4d9b97d1c6645fd3715ac73b4ab45
https://doi.org/10.1182/blood-2022-167056
https://doi.org/10.1182/blood-2022-167056